• Cytokinetics average return on tangible equity for 2023 was 341.61, a 166.99% decline from 2022.
• Cytokinetics average return on tangible equity for 2022 was -509.96, a 172.56% decline from 2021.
• Cytokinetics average return on tangible equity for 2021 was -187.1, a 68.79% increase from 2020.

Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.